ASCO 2026: Key market shifts and considerations

ASCO 2026: Key market shifts and considerations

Every year, ASCO stands as a defining moment in oncology research, and the 2026 meeting was no different. Our team has distilled the conference’s most significant market shifts and strategic imperatives, cutting through the volume to focus on what truly matters. Below...
Where’s the “L” in CVRM?

Where’s the “L” in CVRM?

The move towards a holistic approach is advancing at pace The increasing recognition of biological and clinical interconnection between cardiovascular, renal, and metabolic (CVRM) diseases is clear to see. A shift away from siloed, stepwise treatment approaches...
BHBIA 2026: All change, please, all change

BHBIA 2026: All change, please, all change

Summary: Research isn’t being transformed by tools alone; there’s a broader behavioral shift in where value sits and what clients need from insight partners. Pharma insights teams are building their own insight ecosystems: agency value increasingly comes from...